TCL Archive “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.” July 7, 1995
TCL Archive In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony August 26, 1977
TCL Archive FDA cancer therapeutics review split among three units in reorganization. October 10, 2003
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention April 29, 2005
TCL Archive Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed December 7, 1979
